262 related articles for article (PubMed ID: 38007992)
21. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example.
Guo F; Tang X; Zhang W; Wei J; Tang S; Wu H; Yang H
Pharmacol Res; 2020 Oct; 160():105077. PubMed ID: 32687952
[TBL] [Abstract][Full Text] [Related]
22. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
[No Abstract] [Full Text] [Related]
23. The Effect of Acupuncture on Brain Iron Deposition and Body Iron Metabolism in Vascular Cognitive Impairment: Protocol for a Randomized Controlled Trial.
Wu M; Chen L; Wang Y; Li Y; An Y; Wu R; Zhang Y; Gao J; Su K; Feng X
JMIR Res Protoc; 2024 Jun; 13():e56484. PubMed ID: 38885500
[TBL] [Abstract][Full Text] [Related]
24. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula.
Zhao L; Zhang H; Li N; Chen J; Xu H; Wang Y; Liang Q
J Ethnopharmacol; 2023 Jun; 309():116306. PubMed ID: 36858276
[TBL] [Abstract][Full Text] [Related]
25. Traditional Chinese medicine network pharmacology: theory, methodology and application.
Li S; Zhang B
Chin J Nat Med; 2013 Mar; 11(2):110-20. PubMed ID: 23787177
[TBL] [Abstract][Full Text] [Related]
26. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
27. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning.
Yang J; Tian S; Zhao J; Zhang W
Pharmacol Res; 2020 Sep; 159():105034. PubMed ID: 32565312
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of acupuncture combined with Chinese herbal medicine traditional Chinese medicine for poststroke cognitive impairment: A protocol for a systematic review and meta-analysis.
Wang Y; Guo S; Xiao ML; Zhang H
Medicine (Baltimore); 2022 Mar; 101(9):e29019. PubMed ID: 35244083
[TBL] [Abstract][Full Text] [Related]
29. An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms.
Zhao Q; Bai J; Chen Y; Liu X; Zhao S; Ling G; Jia S; Zhai F; Xiang R
J Ethnopharmacol; 2022 Oct; 297():115567. PubMed ID: 35870684
[TBL] [Abstract][Full Text] [Related]
30. Medicine for chronic atrophic gastritis: a systematic review, meta- and network pharmacology analysis.
Weng J; Wu XF; Shao P; Liu XP; Wang CX
Ann Med; 2023; 55(2):2299352. PubMed ID: 38170849
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression.
Li B; Xu M; Wang Y; Feng L; Xing H; Zhang K
J Ethnopharmacol; 2023 Mar; 303():116038. PubMed ID: 36529248
[TBL] [Abstract][Full Text] [Related]
32. Traditional Chinese medicine for the treatment of pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview.
Li LJ; Chen X; Yang WN; Xu XM; Lu LY; Wang J; Kong YX; Zheng JH
Medicine (Baltimore); 2020 Jul; 99(31):e21310. PubMed ID: 32756114
[TBL] [Abstract][Full Text] [Related]
33. The Neuroprotective Effects of Danggui-Shaoyao San on Vascular Cognitive Impairment: Involvement of the Role of the Low-Density Lipoprotein Receptor-Related Protein.
Cai H; Cai T; Zheng H; Liu L; Zhou L; Pang X; Zhan Q; Wang Y; Yang C; Guo Z; Pan H; Wang Q
Rejuvenation Res; 2020 Oct; 23(5):420-433. PubMed ID: 32242481
[TBL] [Abstract][Full Text] [Related]
34. Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review.
Zheng S; Xue C; Li S; Zao X; Li X; Liu Q; Cao X; Wang W; Qi W; Zhang P; Ye Y
Front Pharmacol; 2024; 15():1381712. PubMed ID: 38694920
[TBL] [Abstract][Full Text] [Related]
35. Systems Pharmacology Dissection of Multiscale Mechanisms of Action for Herbal Medicines in Treating Rheumatoid Arthritis.
Wang J; Li Y; Yang Y; Du J; Zhao M; Lin F; Zhang S; Wang B
Mol Pharm; 2017 Sep; 14(9):3201-3217. PubMed ID: 28771010
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy and safety of traditional Chinese patent medicine for cognitive dysfunction in diabetic cognitive dysfunction: A protocol for systematic review and Bayesian network meta-analysis.
Wang K; Jiang Z; Yu X; Shao Y; Liu H; Wu S; Kong L; Wang Z
Medicine (Baltimore); 2022 Mar; 101(10):e28946. PubMed ID: 35451386
[TBL] [Abstract][Full Text] [Related]
37. Vascular cognitive impairment: disease mechanisms and therapeutic implications.
Levine DA; Langa KM
Neurotherapeutics; 2011 Jul; 8(3):361-73. PubMed ID: 21556678
[TBL] [Abstract][Full Text] [Related]
38. Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.
Li WH; Han JR; Ren PP; Xie Y; Jiang DY
Comput Biol Chem; 2021 Feb; 90():107358. PubMed ID: 33243703
[TBL] [Abstract][Full Text] [Related]
39. A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease.
Shi SH; Cai YP; Cai XJ; Zheng XY; Cao DS; Ye FQ; Xiang Z
PLoS One; 2014; 9(3):e89123. PubMed ID: 24598793
[TBL] [Abstract][Full Text] [Related]
40. Neurovascular glial unit: A target of phytotherapy for cognitive impairments.
Chen L; Zhen Y; Wang X; Wang J; Zhu G
Phytomedicine; 2023 Oct; 119():155009. PubMed ID: 37573807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
